Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
3
Y Combinator, Initialized Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2018 Went through Y Combinator
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
GeneSight1-10 employees
GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. The GeneSight…
ゲノム ( DNA )、エピゲノム、トランスクリプトーム ( RNA )を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス( NGS )/ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Aera Payment & IdentificationFounded 2016 • 51-200 employees
Conversion done right, for web and apps. Boost conversion and basket size with optimized purchase flows and payments.
Atrandi BiosciencesSeries A $25M · 19 mo ago • Founded 2016 • 51-200 employees
Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological…
PhasegenomicsVenture round $4.8M · 3 yr ago • Founded 2015 • 11-50 employees
Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.
In-house DNA and RNA synthesis with Kilobaser DNA & RNA Synthesizer for fastest access to molecular tools. Produce ready-to-use modified…

Overview

Cancer Genomics Done Right.. Why choose between DNA and RNA? Our test analyzes both - genomics and transcriptomics - from a single sample. Information from both available simultaneously from a single work-flow saves tissue, time, money, and effort.